All stock lists
UBS Group AG Registered (New York Stock Exchange:UBS)
CH · Delayed Price · Currency is USD
Also listed: 0R3T.IL, 0R3T.L, UBSG.SWFinancial Services · Banks - Diversified
46.78+0.32 (+0.69%)
Market cap
$143B
Insider Score
Health Score
Analyst consensus
Listed since
May 16, 2000
Website
Insider Score
––Not scored
UBS Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From UBS’s reported statements · Q2 2026 (trailing 12 months)
Profitability16 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $76.03B
- Net income
- $9.52B
- Net margin
- 12.5%
Leverage0 / 20
Heavily indebted for what it earns.
- Total debt
- $375.26B
- Cash
- $217.12B
- Net debt / EBITDA
- 7.48x
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $419.10B
- Current liabilities
- $1071.84B
- Current ratio
- 0.39
Cash generation14 / 20
The business funds itself from operations.
- Operating cash flow
- $5.47B
- Free cash flow
- $3.80B
- FCF margin
- 5.0%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 3083.8M
- Share growth (1y)
- -6.7%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
UBS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 29, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 19.61 B | 19.51 B | 18.39 B | 18.52 B | 18.32 B | 18.93 B |
| Revenue Growth (YoY) | 7.04 % | 3.05 % | 6.97 % | 5.48 % | -0.17 % | -3.37 % |
| Cost of Revenue | 6.02 B | 5.81 B | 6.35 B | 6.69 B | 6.98 B | 7.05 B |
| Gross Profit | 13.58 B | 13.70 B | 12.04 B | 11.84 B | 11.34 B | 11.88 B |
| SG&A Expense | 9.18 B | 8.37 B | 8.38 B | 7.53 B | 7.51 B | 7.96 B |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 9.99 B | 9.86 B | 10.34 B | 9.01 B | 9.14 B | 9.75 B |
| Operating Income | 3.60 B | 3.84 B | 1.70 B | 2.83 B | 2.19 B | 2.13 B |
| Pretax Income | 3.59 B | 3.84 B | 1.70 B | 2.83 B | 2.19 B | 2.13 B |
| Tax Provision | 782.00 M | 786.00 M | 495.00 M | 341.00 M | -209.00 M | 430.00 M |
| Net Income | 2.80 B | 3.04 B | 1.20 B | 2.48 B | 2.40 B | 1.69 B |
| EPS (Basic) | 0.91 | 0.96 | 0.29 | 0.79 | 0.72 | 0.53 |
| EPS (Diluted) | 0.87 | 0.92 | 0.29 | 0.75 | 0.72 | 0.53 |
| Shares Outstanding | 3.08 B | 3.87 B | 3.18 B | 3.18 B | 3.31 B | 3.33 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.